Skip to main content

This project was conceived on the basis of the important economic and sanitary impacts related to bovine mastitis in dairy production as well as on the basis of the restrictions on the use of antibiotics as a means of treatment of this pathology. Its objective is the development of phage-based products for the treatment of bovine mastitis, targeting for the moment two of its major pathogens, S. aureus and E. coli.

A consortium formed by two industrial partners and two academic partners will have to build up a phage bank against the two target bacteria (WP1), develop a “phagogram” capable of selecting and proposing phages that are active on these bacteria in milk (WP2) and finally develop a specific formulation (WP3) based on these phages for the treatment of mastitis in cows during the lactation period (WP4). This innovative project on several levels will lead to numerous spin-offs, mainly on the economic level, sustainable development and job creation.

*This BioWin portfolio project is co-sponsored by the Wagralim cluster

Consortium 

Companies: Vesale Biosciences, DNAlytics

Universities : ULiège

Research center: Centre Wallon de Recherche Agronomique

Contact :

Cyrille NGASSAM: c.ngassam@vesalepharma.com

Leave a Reply